Therese Surges’ world was turned upside down when her husband and love of her life, Keith, was diagnosed with appendiceal adenocarcinoma and PMP in 2010. Therese took this challenge head-on and proceeded to learn everything she could about Keith’s illness to support him in the best possible way. She stood steadfastly by Keith’s side for the next several years: his caregiver, his confidante, his...

ACPMP is very excited to announce the launch of our newly designed website. After six months of hard work, we are delighted to announce the launch of the new and improved acpmp.org! The new website is easier to navigate, more user-friendly, and features new updates to pages such as Patient Stories. Our goal with this new website is to provide our...

Inspire is a free and secure online support community in which patients connect with one another for support and information. ACPMP has been a partner with Inspire for the past 10 years and has cultivated a wonderful support community for appendix cancer and PMP patients with over 1,900 members! We are excited to share with you Inspire's new mobile app!...

The ACPMP Research Foundation is excited to announce that we have become official advocacy partners of the MyPART Network at the U.S. National Cancer Institute’s Center for Cancer Research! The My Pediatric and Adult Rare Tumor (MyPART) Network is a group of patients, family members, researchers, advocates, and healthcare providers who are working together to find treatments for childhood, teen,...

ACPMP celebrated #GivingTuesday 2019 by sharing videos from our Board of Directors and staff in the week leading up to it! Their stories will tug at your heartstrings when you learn how they all have been individually impacted by Appendix Cancer/PMP. We hope these videos inspired you, gave you hope, and showed you just how personal this fight truly is...

The ACPMP Research Foundation continues to follow with great interest the clinical research being conducted to identify appendiceal tumor characteristics against which novel drugs can be targeted to reduce, if not eliminate, disease.  We were pleased, therefore, with the recent addition to our website’s list of clinical trials of a currently recruiting Phase 1 clinical study of patients with solid...

The Appendix Cancer / Pseudomyxoma Peritonei Research Foundation (ACPMP) is pleased to announce the recipients of our 2018 research grant cycle. With these two grants, ACPMP has now issued $1,200,000 in the form of 25 promising research grants over the past 10 years designed to improve the diagnosis and treatment of Appendix Cancer and Pseudomyxoma Peritonei. These grants are issued...

The ACPMP Research Foundation is committed to financial transparency. We want our donors to know how every dollar they donate is spent. Our 2018 IRS Form 990 and Reviewed Financial Statements are available for review at our Donor Confidence page, and our 2018 Impact Report shows what we achieved in 2018. We are proud to once again be a Platinum Level Participant on the GuideStar Exchange,...

The Appendix Cancer / Pseudomyxoma Peritonei Research Foundation (ACPMP) sponsored and participated in the 14th Annual International Symposium on Regional Cancer Therapies, presented by the Society of Surgical Oncology, which took place from February 16-18, 2019 at the Arizona Grand Resort in Phoenix, AZ. ACPMP expanded our investment in this exciting event by providing funding for three travel scholarships enabling young physicians...

Professor David Morris joined ACPMP for Rare Disease Day on February 28, 2019 to provide an update on the research funded by ACPMP in 2016 that has led to a Phase I clinical trial.